Evotec Restructuring Aims To Improve Profitability After Transition Year

Benzinga_recent_news

03/11

Evotec SE (NASDAQ:EVO) stock is trading lower on Tuesday. The drug discovery firm announced a new strategic transformation initiative called "Horizon," aimed at reshaping its operating model, ...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2618983963"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618983963\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618983963?lang=zh_CN&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/10/Pinterest-Limits-Layoff-Details.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-03-11 02:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618983963","market":"us","top_or_hot":-1,"title":"Evotec Restructuring Aims To Improve Profitability After Transition Year","media":"Benzinga_recent_news","content":"<div>\n<p>Evotec SE (NASDAQ:EVO) stock is trading lower on Tuesday.\nThe drug discovery firm announced a new strategic transformation initiative called \"Horizon,\" aimed at reshaping its operating model, ...</p>\n\n<a href=\"https://www.benzinga.com/markets/guidance/26/03/51169516/evotec-restructuring-aims-to-improve-profitability-after-transition-year\">网页链接</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evotec Restructuring Aims To Improve Profitability After Transition Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvotec Restructuring Aims To Improve Profitability After Transition Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-11 02:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/guidance/26/03/51169516/evotec-restructuring-aims-to-improve-profitability-after-transition-year><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Evotec SE (NASDAQ:EVO) stock is trading lower on Tuesday.\nThe drug discovery firm announced a new strategic transformation initiative called \"Horizon,\" aimed at reshaping its operating model, ...</p>\n\n<a href=\"https://www.benzinga.com/markets/guidance/26/03/51169516/evotec-restructuring-aims-to-improve-profitability-after-transition-year\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://www.benzinga.com/markets/guidance/26/03/51169516/evotec-restructuring-aims-to-improve-profitability-after-transition-year","article_id":"2618983963","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/10/Pinterest-Limits-Layoff-Details.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/guidance/26/03/51169516/evotec-restructuring-aims-to-improve-profitability-after-transition-year","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2618983963","pubTimestamp":1773167220,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Evotec launches transformation plan, targeting 75 million euros in savings by 2027 and revenue above 1 billion euros by 2030.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","EVO":"Evotec SE"},"translate_title":"Evotec重组旨在提高过渡年后的盈利能力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVO":1},"content_text":"Evotec SE (NASDAQ:EVO) stock is trading lower on Tuesday.\nThe drug discovery firm announced a new strategic transformation initiative called \"Horizon,\" aimed at reshaping its operating model, improving margins, and positioning the company for long-term growth in the drug discovery and preclinical development market.\nThe initiative builds on the company's earlier \"Priority Reset\" and strategic roadmap introduced over the past two years.\n“Horizon positions Evotec for stronger performance through 2027 and lays the foundation for further optimization and intelligent scaling toward 2030,\" Christian Wojczewski, Evotec CEO, said.\nAs part of the transformation, Evotec will simplify its organizational structure and consolidate its global expertise into new Centers of Excellence designed to strengthen scientific collaboration and innovation.\nThe company also plans to reduce its global site footprint from 19 locations in 2024 to 10 sites over the next two years.\nThe restructuring is expected to affect up to 800 positions across various locations.\nImplementation of Horizon has already begun, with initial operational effects anticipated in the second half of 2026.\nThe transformation is expected to be substantially completed by the end of 2027.\nThe initiative is projected to generate approximately 75 million euros (around $87.3 million) in annual run-rate cost savings by 2027.\nTo implement Horizon, Evotec expects restructuring-related cash charges of roughly 100 million euros between 2026 and 2028, along with potential non-cash impairment charges.\nEvotec also shared preliminary fiscal 2025 sales of about 788 million euros and adjusted EBITDA of roughly 41 million euros, both within its previously communicated guidance.\nLooking ahead to 2026, the company expects revenue between 700 million and 780 million euros and adjusted EBITDA of 0 to 40 million euros, reflecting what executives described as a transition year during the restructuring process.\nOver the longer term, Evotec expects revenues to exceed 1 billion euros between 2026 and 2030, with adjusted EBITDA margins projected to reach 20% by 2028 and surpass that level by the end of the decade.\nEVO Price Action: Evotec shares were down 10.40% at $2.71 at the time of publication on Tuesday. The stock is trading at a new 52-week low, according to Benzinga Pro data.\nImage via Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}